pharmaceutical industry | World Briefings
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

Insulin Biosimilars Market Expected to Reach $5.41 Billion by 2028: Growth Driven by Rising Diabetes Prevalence

Business

27 Sep, 2024

Insulin Biosimilars Market Expected to Reach $5.41 Billion by 2028: Growth Driven by Rising Diabetes Prevalence


The insulin biosimilars market is poised for significant growth in the coming years, driven by several key factors. The global...

Gelatin Market Booming: Demand Soaring, Companies Strategizing for Growth

Business

25 Sep, 2024

Gelatin Market Booming: Demand Soaring, Companies Strategizing for Growth


The global gelatin market is surging, fueled by a robust demand from diverse industries, particularly in the food and pharmaceutical...

Prostate Cancer Treatment Market: A $10 Billion Industry Facing New Challenges and Opportunities

Business

10 Sep, 2024

Prostate Cancer Treatment Market: A $10 Billion Industry Facing New Challenges and Opportunities


The global prostate cancer treatment market is experiencing robust growth, driven by a confluence of factors. The rising prevalence of...

Lexaria Bioscience Appoints New CEO as Company Transitions to Focus on Pharmaceutical Industry Collaboration

Business

9 Sep, 2024

Lexaria Bioscience Appoints New CEO as Company Transitions to Focus on Pharmaceutical Industry Collaboration


Lexaria Bioscience Corp. (NASDAQ:LEXX) is embarking on a new era with a renewed focus on pharmaceutical industry collaborations and advancing...

IPF Market Growth: Rising Incidence, New Treatments, and the $4 Billion Opportunity

World

5 Sep, 2024

IPF Market Growth: Rising Incidence, New Treatments, and the $4 Billion Opportunity


Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease that causes scarring in the lungs, leading to difficulty breathing....

Biologics CDMO Market Booming: $35 Billion by 2031, Driven by Increasing Demand for Novel Therapeutics

Business

4 Sep, 2024

Biologics CDMO Market Booming: $35 Billion by 2031, Driven by Increasing Demand for Novel Therapeutics


The global biologics CDMO market is experiencing significant growth and presents numerous opportunities for companies in this space. Understanding the...

Top Biopharma Companies Witness 4.3% Market Cap Growth in Q2 2024, GLP-1 Innovators Lead the Pack

Business

21 Aug, 2024

Top Biopharma Companies Witness 4.3% Market Cap Growth in Q2 2024, GLP-1 Innovators Lead the Pack


The global biopharmaceutical industry demonstrated resilience in the second quarter (Q2) of 2024, with the top 20 companies reporting a...

PD-1 and PD-L1 Inhibitor Market Booming: A $100 Billion Industry by 2028?

Business

20 Aug, 2024

PD-1 and PD-L1 Inhibitor Market Booming: A $100 Billion Industry by 2028?


The fight against cancer has entered a new era, marked by the emergence of innovative therapies that target the immune...

Immunotherapy Drugs Market Booming:  15.61% CAGR Forecast to 2031 - What's Driving This Growth?

Business

10 Aug, 2024

Immunotherapy Drugs Market Booming: 15.61% CAGR Forecast to 2031 - What's Driving This Growth?


Immunotherapy drugs are revolutionizing cancer treatment by harnessing the body's own immune system to target and destroy cancer cells. This...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates